View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Matthew Weiss ... (+2)
  • Matthew Weiss
  • Scott Devitt

2Q25 Postmortem: Sentiment Guide Following Results

Following 2Q results, momentum seems most favorable for the companies below:META (Outperform) - While sentiment was already elevated ahead of the print, 2Q results were strong and guidance for 3Q was encouraging, with expectations for revenue growth ahead of initial St. estimates by ~700bps. Additi

Antoine Legault ... (+2)
  • Antoine Legault
  • Matthew Bryson

WEDBUSH INVITE | Q&A with Yuanta Supply Chain Analyst | Wednesday 8/20...

Airoha Technology Corp 6526, ASE Technology Holding 3711, United Microelectronics 2303, MediaTek Inc 2454, Amkor Technology Inc AMKR, Intel Corp INTC, Taiwan Semiconductor 2330, Fitipower Integrated Tech 4961, ASMedia Technology Inc 5269, Raydium Semiconductor 3592, and Parade Technologies Ltd 4966

Wayfair Inc: 2 directors

Two Directors at Wayfair Inc sold 51,105 shares at between 77.208USD and 77.210USD. The significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...

Etsy Inc: 1 director

A director at Etsy Inc sold 11,944 shares at 59.315USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

Dan Salmon
  • Dan Salmon

The Trade Desk (TTD, Neutral, $75 target) Continued revenue decelerati...

In this first take following tonight’s results, we touch on: 1. 3Q25 revenue deceleration hangs over the stock 2. Management remains confident that Amazon DSP is not a competitor 3. Kokai adoption reaches three quarters of spend 4. CFO transition announced, other leadership changes evolve go-to-market

Dan Salmon
  • Dan Salmon

Shopify (SHOP, Neutral, $105 target) GMV/revenue acceleration and AI e...

In this first take following this morning’s results we focus on: 1. 1st stock upside driver is 3Q25 revenue guidance, the second 2nd leg is AI enthusiasm 2. GMV and revenue strength are the star of today’s show 3. Latest AI innovations target a future of agentic commerce 4. Gross profit lags revenue as absolute dollar growth remains the focus 5. FCF margin outlook unchanged as reinvestment remains the focus

 PRESS RELEASE

Costco Wholesale Corporation Reports July Sales Results

Costco Wholesale Corporation Reports July Sales Results ISSAQUAH, Wash., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $20.89 billion for the retail month of July, the four weeks ended August 3, 2025, an increase of 8.5 percent from $19.26 billion last year. Net sales for the first 48 weeks were $248.35 billion, an increase of 8.1 percent from $229.81 billion last year. Comparable sales were as follows:  4 Weeks 48 WeeksU.S.5.5% 6.2%Canada7.6% 4.9%Other International9.5% 4.6%    Total Company6.4% 5.8...

Dan Salmon
  • Dan Salmon

Amazon (AMZN, Buy, $270 target) AWS adds OpenAI open weight models (an...

Earlier today, OpenAI released its promised open weight models and they are available on a variety of platforms, including AWS and Azure but not GCP. This is the first time any OpenAI models have been available through AWS.

Amazon Com Inc: 1 director

A director at Amazon Com Inc sold 2,500 shares at 217.000USD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

Dan Salmon
  • Dan Salmon

Amazon (AMZN, Buy, raising target to $270) How OpenAI could unleash th...

AMZN remains our Top Pick, based on 2H25/1H26 AWS revenue acceleration, albeit lagging GCP and Azure. That AWS appears to be more capacity constrained than Azure and GCP is not a big surprise. MSFT has the largest base of GPUs, while GOOGL has a larger custom silicon base. We expect AWS to accelerate as it closes the gap on custom silicon, ramping into Trainium3 later this year.

Matthew Weiss ... (+2)
  • Matthew Weiss
  • Scott Devitt

Margin Trajectory Improving; Neutral, $70 PT

Figure 1. 2Q25 Results vs. EstimatesSource: Company reports, Wedbush estimates, FactSet consensusWayfair reported healthy 2Q25 results with revenue and adj. EBITDA ahead of consensus expectations. In the quarter, Wayfair reported revenue of $3.3B (+5.0% Y/Y), ~5% ahead of expectations, and adj. EBI

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
HURN HURON CONSULTING GROUP INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BZH BEAZER HOMES USA INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
INOD INNODATA
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
CVCO CAVCO INDUSTRIES INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ROKU ROKU INC. CLASS A
ISR ISORAY
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
UBER UBER TECHNOLOGIES INC.
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
PLTR PALANTIR TECHNOLOGIES
VRDN VIRIDIAN THERAPEUTICS INC
IMNM IMMUNOME
PLTK PLAYTIKA HOLDING
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
STX SEAGATE TECHNOLOGY HLDGS PLC
ATXS ASTRIA THERAPEUTICS INC
GFS GLOBALFOUNDRIES INC
GMTX GEMINI THERAPEUTICS INC
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
APGE APOGEE THERAPEUTICS INC
SKLZ SKILLZ INC
EMBRAC B EMBRACER GROUP AB
DNTH DIANTHUS THERAPEUTICS INC
TLX TELIX PHARMACEUTICALS LIMITED
MAZE MAZE THERAPEUTICS INC
Daniel Ives ... (+3)
  • Daniel Ives
  • Matthew Weiss
  • Scott Devitt

Expectations Investing; OP, $250 PT

Figure 1. 2Q25 ResultsSource: Company reports, Wedbush estimates, FactSet consensusGuidance notes: 2Q total revenue guidance of $159B to $164B; 2Q operating income guidance of $13.0B to $17.5B.In 2Q, total revenues grew +13.3% Y/Y, ~3% ahead of expectations, driven by outperformance across all segm

Dan Salmon
  • Dan Salmon

Amazon (AMZN, Buy, $260 target) AWS’s day is coming, but today is not ...

In this first take following tonight’s results, we focus on: 1. AWS revenue growth beats consensus but the real question is 2H acceleration 2. Increased 2025 capex guidance no surprise but no early hints for 2026 3. Custom silicon, price, and incumbent workloads define the long-term AWS AI strategy 4. Tariff uncertainty weighs on retail outlook, but underlying fundamentals remain strong

Matthew Weiss ... (+2)
  • Matthew Weiss
  • Scott Devitt

Back To The Future; Neutral, $90 PT

Figure 1. 2Q25 ResultsSource: Company reports, Wedbush estimates, FactSet consensuseBay reported strong 2Q results. GMV increased +6.0% Y/Y in the quarter to $19.5B, ahead of the Street's +2.5% Y/Y estimate, and revenue of $2.7B (+6.1% Y/Y) was ~3% ahead of expectations. Advertising revenue grew +2

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch